In consideration of stronger binding to AD-related tau tangles compared to 4R-tau aggregates in primary tauopathies, the availability of a tau tracer with higher affinity to non-AD tau could even lead to stronger tau-related effects in the group of patients with 4R-tauopathies. Here, MAPT is linked to Alzheimer disease.